Skip to main content

2BMED · BANCA MEDIOLANUM SPA · Financials

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Net Income
1.24B +10.6%
FY2025 Net Income FY2020–FY2025
Operating Cash Flow
389.84M -66.2%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
EUR 804.8M 789.91M 710.42M 648.47M 613.03M 562.17M
EUR 1.43B 1.45B 1.07B 643.84M 890.47M 531.42M
EUR 191.75M 331.07M 245.32M 137.01M 177.41M 96.96M
EUR 1.24B 1.12B 821.87M 506.83M 713.06M 434.46M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: 3.08B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.